Sharp Therapeutics Corp is a biology technology company. The group focused on genetic diseases. It has developed the CoreX, biology, AlloChem, chemistry, and Disco, computational technologies allowing to discovery of small molecules that restore activity in mutated proteins, or that increase activity in the normal copy of the gene in the case where only a single unmutated gene remains (haploinsufficiency. The company applies these technologies across a portfolio of diseases of high unmet medical need.
No Data